What Cryoskin does

Artemis Distribution LLC, which markets its portfolio under the Cryoskin, Artemis, and Neveskin brand names, is a U.S.-based B2B distributor and advertising partner for non-invasive aesthetic medical devices. The company distributes a clinically recognized product portfolio including Neogen (a nitrogen plasma skin regeneration device with seven FDA clearances for skin types I-IV), T-Shape 2 (a multi-technology face and body system combining bipolar radiofrequency, low-level laser therapy, endodermic massage, and mesospheric activation), Soft FX (an AI-powered skin, hair, and body analysis device priced at $13,440), InfraBaldan (a photobiomodulation system), Cryoskin/Neveskin (cryotherapy-based skin treatment platforms), and Plason (atmospheric plasma plus ultrasonic). The company also supplies proprietary consumables (gels, serums, filters, calibration kits, replacement nozzles and handpieces) that are largely available on auto-billed subscription.

The business operates through a hybrid go-to-market model that combines consultative enterprise device sales with a managed performance-based advertising partnership. Devices require business verification, contract execution, and mandatory training certification before delivery (typically 1–3 months), and partners are enrolled in a program in which Artemis runs paid social campaigns on Meta and Google, operates a call center for lead follow-up and deposit collection, and books appointments directly into the practice schedule — charging only for patients who actually show. The company targets primarily medical spas, dermatology and plastic surgery clinics, wellness and rejuvenation centers, and secondarily gyms, bariatric clinics, and salons/spas across 150+ partner locations in the U.S., with an emerging U.K. support presence. Revenue is generated across five streams: one-time device sales, recurring consumable subscriptions, $3,000/year device maintenance service packages, training certifications ($100–$2,500), and performance-based advertising fees.

Anchoring the strategy is an explicit focus on the aesthetic consequences of GLP-1-driven rapid weight loss ("Ozempic face," "Ozempic butt"), positioning the device portfolio as the non-invasive, no-downtime response that practices need to capture this patient cohort. The company is privately held, founder-led (CEO Simon Mansell, formerly of Cryofuel; VP Product & Brand Experience Delaney Allen-Mills), and reports 11–50 employees with U.S. headquarters in Rye Brook, NY and a U.K. support office in London.

Name

Cryoskin

Legal name

Artemis Distribution LLC

Website

https://cryoskin.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Artemis Distribution is a U.S.-based B2B distributor and advertising partner that sells non-invasive aesthetic devices (Neogen, T-Shape 2, Soft FX, InfraBaldan, Cryoskin) to medical spas, dermatology clinics, and wellness centers, combined with managed paid-social lead generation and consumable subscriptions for 150+ partner practices.

Ownership category

akta.pro rank

Product category

Aesthetic Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hot/Cold Therapy Services (Cryotherapy/Ice Baths) (HSALAFAH)

akta.pro secondary industry

Cryotherapy Services (HSADAKAE)

Keywords

• Aesthetic medical devices
• Cryotherapy body contouring
• Non-invasive skin tightening
• Radiofrequency aesthetic systems
• AI skin analysis devices

Headquarters

HQ city

Rye

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Marketing or Sales, Supply Chain, Operations, Personnel, Technology or R&D

Revenue model

1. Device Sales: Sale of aesthetic devices including T-Shape 2, Neogen, InfraBaldan, and Soft FX. Devices require mandatory onboarding process including business verification, contract completion, and training. Delivery typically takes 1-3 months after purchase.
2. Consumables: Recurring sales of gels, oils, serums, filters, cleaning solutions, and skincare products required for device operation. Many consumables available on subscription basis with automatic billing.
3. Service and Maintenance: Annual maintenance service packages for devices at $3,000 per device. Repair services with transparent pricing where customers pay only for repairs when required.
4. Training and Certifications: Online and in-person training certifications for device operation. Pricing ranges from $100 for online courses to $2,500 for comprehensive certifications.
5. Performance-Based Advertising Fees: Artemis charges partners only for each patient who shows up for their appointment, handling all advertising creative, ad spend management on Meta and Google, and appointment booking at no upfront cost to the practice.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels9 records

Core offering

Cryoskin is a non-invasive cryotherapy-based skin treatment brand operated by Artemis Distribution LLC. The company distributes clinically recognized aesthetic devices (T-Shape 2, Neogen, Soft FX, InfraBaldan, Plason, Neveskin) to aesthetic practices that deliver Cryoskin-branded skin firming, toning, fat reduction, and cellulite reduction treatments. Beyond hardware, the company offers managed advertising partnerships, training certifications, consumables, and maintenance services.

Product overview

Artemis Distribution is a B2B aesthetic device distributor and advertising partnership company that offers a portfolio of clinically recognized, FDA-cleared non-invasive aesthetic technologies. The core product portfolio includes Neogen (nitrogen plasma skin regeneration for facial rejuvenation), T-Shape 2 (multi-technology face and body system combining radiofrequency, laser, suction, and mesospheric activation), Soft FX (AI-powered skin analysis device), and InfraBaldan (photobiomodulation for fat reduction while maintaining muscle). Additionally, Artemis supports Cryoskin's CryoFacial platform as a referenced treatment modality. The portfolio includes comprehensive consumables (gels, serums, filters, oils, calibration kits), interchangeable handpieces and accessories, annual maintenance services, and branded clinical training certification programs. Artemis positions itself as a full-service partner providing devices, marketing support, and ongoing operational guidance to aesthetic practices.

Differentiator

Problem solved

Functional benefit

Brands

• T-Shape 2: Italy's #1 face and body treatment system combining bipolar radiofrequency, low-level laser therapy, endodermic massage with suction, and mesospheric activation for non-invasive sculpting, toning, and skin tightening.
• Neogen
• InfraBaldan
• Soft FX
• Neveskin
• Cryoskin
• Plason

Quantifiable outcome

• Increase in muscle-to-fat ratio of 23% after 10 T-Shape 2 treatments
• +4 more outcomes

Named customers7 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature4 records

Partnerships

One partnership is on record.

• Baldan GroupcoreStrategic or Co-development PartnerArtemis partnered with Baldan Group to bring T-Shape 2 and InfraBaldan devices to the U.S. market. Baldan had existing sales representatives in the U.S., which were maintained through this partnership. Both companies sell the devices at identical pricing, and both sales teams report to Simon Mansell, CEO of Artemis, ensuring unified U.S. market strategy. The partnership offers flexibility: customers can purchase from either Baldan (with Italian-managed training and support) or Artemis (with local U.S. training, support, and participation in consumer marketing campaigns via TryTShape.com).

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Sciton: Aesthetic and medical laser manufacturer offering platforms like BBL (skin rejuvenation), Halo, and Profractional used by medspas and dermatology practices. Competes in the same non-ablative skin rejuvenation category as Neogen.
• Venus Concept: Aesthetic device company offering Venus Bliss (body contouring), Venus Viva (skin resurfacing), and Venus Versa sold through a similar subscription-pricing model to medspas and aesthetic practices. Competes directly in the same SMB practitioner channel.
• InMode: Public medical device company offering non-invasive aesthetic platforms (BodyTite, Morpheus8, Evolve) used by medspas and plastic surgeons for body contouring and skin remodeling. Competes head-to-head with T-Shape 2 in RF-based body and facial treatments.
• Cynosure: Aesthetic and medical device company offering laser, RF, and body contouring systems (TempSure, Potenza) to medical spas and dermatology clinics. Directly competes in non-invasive skin tightening and facial rejuvenation categories.
• BTL Industries: Manufacturer of non-invasive aesthetic devices including EMSCULPT (muscle toning), EMFACE (facial toning), and EMSELLA, sold to medspas and aesthetic practices. Direct competitor in the non-invasive body contouring and skin firming categories where Artemis sells T-Shape 2 and Neogen.
• Cutera: Aesthetic device manufacturer offering platforms like truSculpt (body contouring), Secret RF (skin rejuvenation), and AviClear (acne). Sells through a similar aesthetic practitioner channel and competes in RF-based skin tightening and body sculpting.
• Solta Medical: Aesthetic device brand (owned by Bausch Health) offering Thermage (RF skin tightening), Fraxel (laser resurfacing), and Liposonix (body contouring). Competes with Neogen in skin regeneration and with T-Shape 2 in non-invasive skin tightening.

Broad incumbents

• Alma Lasers: Global aesthetic and medical laser manufacturer with a broad portfolio including Soprano, Accent, and Harmony platforms used in hair removal, body contouring, and skin rejuvenation. A broader incumbent across multiple aesthetic device categories where Artemis competes.
• Lumenis: Established aesthetic and ophthalmic device company (owned by Boston Scientific) offering energy-based platforms for skin rejuvenation, hair removal, and body contouring. A broader incumbent with overlapping categories to Artemis's portfolio.
• Allergan Aesthetics (AbbVie): Aesthetic pharmaceutical and device business (CoolSculpting, SkinMedica) operating broadly in non-invasive body contouring and skincare. Competes as a larger incumbent with greater marketing resources and a wider practitioner footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/artemisdistribution
• Facebookfacebook.com/cryoskinus
• Instagraminstagram.com/artemis.us

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cryoskin